The pluripotency homeobox gene NANOG is expressed in human germ cell tumors

Cancer

Volumn 104, Issue 10, 2005, Pages 2092-2098

  Hart, Adam H ^a   Hartley, Lynne ^a   Parker, Karen ^a   Ibrahim, Marilyn ^a   Looijenga, Leendert H J ^b   Pauchnik, Marija ^c   Chow, Chung Wo ^c   Robb, Lorraine ^a  

^a WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b JOSEPHINE NEFKENS INSTITUTE   (Netherlands)

^c ROYAL CHILDREN'S HOSPITAL   (Australia)

Author keywords

Embryonal; Germ cell; Germ cells; NANOG protein; Neoplasms; pou5f1 transcription factor

Indexed keywords

DNA BINDING PROTEIN; OCTAMER TRANSCRIPTION FACTOR 4; TRANSCRIPTION FACTOR;

ARTICLE; CARCINOGENESIS; CARCINOMA IN SITU; CELL DIFFERENTIATION; CELL RENEWAL; CHROMOSOME 12P; CONTROLLED STUDY; EMBRYO; EMBRYONAL CARCINOMA; EMBRYONIC STEM CELL; GENE; GENE EXPRESSION; GENE LOCATION; GENE NUMBER; GERM CELL TUMOR; HOMEOBOX; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; NANOG GENE; NUCLEOTIDE SEQUENCE; PLURIPOTENT STEM CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEMINOMA; TERATOMA; TUMOR CLASSIFICATION; TUMOR DIAGNOSIS; UNDIFFERENTIATED CARCINOMA; YOLK SAC TUMOR;

DNA-BINDING PROTEINS; FETUS; GENE DOSAGE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HOMEODOMAIN PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; NEOPLASMS, GERM CELL AND EMBRYONAL; OCTAMER TRANSCRIPTION FACTOR-3; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SPERMATOZOA; TRANSCRIPTION, GENETIC; TUMOR MARKERS, BIOLOGICAL;

EID: 27644448817     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.21435     Document Type: Article

References (36)

1. McGlynn KA, Devesa SS, Sigurdson AJ, et al. Trends in the incidence of testicular germ cell tumors in the United States. Cancer. 2003;97:63-70.
2. van Echten J, van Gurp RJ, Stoepker M, et al. Cytogenetic evidence that carcinoma in situ is the precursor lesion for invasive testicular germ cell tumors. Cancer Genet Cytogenet. 1995;85:133-137.
3. Oosterhuis JW, Looijenga LH. Testicular germ-cell tumours in a broader perspective. Nat Rev Cancer. 2005;5:210-222.
4. Looijenga LH, Oosterhuis JW. Pathogenesis of testicular germ cell tumours. Rev Reprod. 1999;4:90-100.
5. Chambers I, Colby D, Robertson M, et al. Functional expression cloning of NANOG, a pluripotency sustaining factor in embryonic stem cells. Cell. 2003;113:643-655.
6. Hart AH, Hartley L, Ibrahim M, et al. Identification, cloning and expression analysis of the pluripotency promoting NANOG genes in mouse and human. Dev Dyn. 2004;230: 187-198.
7. Zafarana G, Grygalewicz B, Gillis AJ, et al. 12p-amplicon structure analysis in testicular germ cell tumors of adolescents and adults by array CGH. Oncogene. 2003;22:7695-7701.
8. Chambers I, Smith A. Self-renewal of teratocarcinoma and embryonic stem cells. Oncogene. 2004;23:7150-7160.
9. Almstrup K, Hoei-Hansen CE, Wirkner U, et al. Embryonic stem cell-like features of testicular carcinoma in situ revealed by genome-wide gene expression profiling. Cancer Res. 2004;64:4736-4743.
10. Dimitriadis E, Salamonsen LA, Robb L. Expression of interleukin-11 during the human menstrual cycle: coincidence with stromal cell decidualization and relationship to leukaemia inhibitory factor and prolactin. Mol Hum Reprod. 2000; 6:907-914.
11. Murphy CL, Polak JM. Differentiating embryonic stem cells: GAPDH, but neither HPRT nor beta-tubulin is suitable as an internal standard for measuring RNA levels. Tissue Eng. 2002;8:551-559.
12. Looijenga LH, Rosenberg C, van Gurp RJ, et al. Comparative genomic hybridization of microdissected samples from different stages in the development of a seminoma and a non-seminoma. J Pathol. 2000;191:187-192.
13. Gaskell TL, Esnal A, Robinson LL, et al. Immunohistochemical profiling of germ cells within the human fetal testis: identification of three subpopulations. Biol Reprod. 2004;71: 2012-2021.
14. Kehler J, Tolkunova E, Koschorz B, et al. Oct4 is required for primordial germ cell survival. EMBO Rep. 2004;5:1078-1083.
15. Looijenga LH, Stoop H, de Leeuw HP, et al. POU5F1 (OCT3/4) identifies cells with pluripotent potential in human germ cell tumors. Cancer Res. 2003;63:2244-2250.
16. Looijenga LH, Oosterhuis JW. Pathobiology of testicular germ cell tumors: views and news. Anal Quant Cytol Histol. 2002;24:263-279.
17. Sandberg AA, Meloni AM, Suijkerbuijk RF. Reviews of chromosome studies in urological tumors. III. Cytogenetics and genes in testicular tumors. J Urol. 1996;155:1531-1556.
18. Atkin NB, Fox MF, Baker MC, et al. Chromosome 12-containing markers, including two dicentrics, in three i(12p)-negative testicular germ cell tumors. Genes Chromosomes Cancer. 1993;6:218-221.
19. Roelofs H, Mostert MC, Pompe K, et al. Restricted 12p amplification and RAS mutation in human germ cell tumors of the adult testis. Am J Pathol. 2000;157:1155-1166.
20. Mitsui K, Tokuzawa Y, Itoh H, et al. The homeoprotein Nanog is required for maintenance of pluripotency in mouse epiblast and ES cells. Cell. 2003;113:631-642.
21. Monk M, Holding C. Human embryonic genes re-expressed in cancer cells. Oncogene. 2001;20:8085-8091.
22. Niwa H, Miyazaki J, Smith AG. Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells. Nat Genet. 2000;24:372-376.
23. Palmieri SL, Peter W, Hess H, et al. Oct-4 transcription factor is differentially expressed in the mouse embryo during establishment of the first two extraembryonic cell lineages involved in implantation. Dev Biol. 1994;166:259-267.
24. Rajpert-De Meyts E, Hanstein R, Jorgensen N, et al. Developmental expression of POU5F1 (OCT-3/4) in normal and dysgenetic human gonads. Hum Reprod. 2004;19:1338-1344.
25. Cheng L. Establishing a germ cell origin for metastatic tumors using OCT4 immunohistochemistry. Cancer. 2004;101: 2006-2010.
26. Durcova-Hills G, Ainscough J, McLaren A. Pluripotential stem cells derived from migrating primordial germ cells. Differentiation. 2001;68:220-226.
27. Resnick JL, Bixler LS, Cheng L, et al. Long-term proliferation of mouse primordial germ cells in culture. Nature. 1992;359: 550-551.
28. Oosterhuis JW, Looijenga LH, van Echten J, et al. Chromosomal constitution and developmental potential of human germ cell tumors and teratomas. Cancer Genet Cytogenet. 1997;95:96-102.
29. Skakkebaek NE, Berthelsen JG, Giwercman A, et al. Carcinoma-in-situ of the testis: possible origin from gonocytes and precursor of all types of germ cell tumours except spermatocytoma. Int J Androl. 1987;10:19-28.
30. Jorgensen N, Rajpert-De Meyts E, Graem N, et al. Expression of immunohistochemical markers for testicular carcinoma in situ by normal human fetal germ cells. Lab Invest. 1995; 72:223-231.
31. Almstrup K, Hoei-Hansen CE, Nielsen JE, et al. Genome-wide gene expression profiling of testicular carcinoma in situ progression into overt tumours. Br J Cancer. 2005;92: 1934-1941.
32. Skotheim RI, Lothe RA. The testicular germ cell tumour genome. APMIS. 2003;111:136-150; discussion 50-51.
33. Sperger JM, Chen X, Draper JS, et al. Gene expression patterns in human embryonic stem cells and human pluripotent germ cell tumors. Proc Natl Acad Sci U S A. 2003;100: 13350-13355.
34. Honecker F, Stoop H, de Krijger RR, et al. Pathobiological implications of the expression of markers of testicular carcinoma in situ by fetal germ cells. J Pathol. 2004;203:849-857.
35. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C[T]) Method. Methods. 2001;25:402-408.
36. Hoei-Hansen CE, Almstrup K, Nielsen JE, et al. Stem cell pluripotency factor NANOG is expressed in human fetal genocytes, testicular carcinoma in situ and germ cell tumours. Histopathology. 2005;47:48-56.